These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21237201)

  • 1. Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background.
    Saunders NJ; Trivedi UH; Thomson ML; Doig C; Laurenson IF; Blaxter ML
    J Infect; 2011 Mar; 62(3):212-7. PubMed ID: 21237201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum.
    Nimmo C; Doyle R; Burgess C; Williams R; Gorton R; McHugh TD; Brown M; Morris-Jones S; Booth H; Breuer J
    Int J Infect Dis; 2017 Sep; 62():44-46. PubMed ID: 28716462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.
    Black PA; de Vos M; Louw GE; van der Merwe RG; Dippenaar A; Streicher EM; Abdallah AM; Sampson SL; Victor TC; Dolby T; Simpson JA; van Helden PD; Warren RM; Pain A
    BMC Genomics; 2015 Oct; 16():857. PubMed ID: 26496891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
    PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran.
    Mohajeri P; Sadri H; Farahani A; Norozi B; Atashi S
    Microb Drug Resist; 2015 Jun; 21(3):315-9. PubMed ID: 25526063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
    Kabir S; Junaid K; Rehman A
    Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    Lobie TA; Woldeamanuel Y; Asrat D; Beyene D; Bjørås M; Aseffa A
    PLoS One; 2020; 15(4):e0231320. PubMed ID: 32267877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
    Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL
    J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran.
    Bahrmand AR; Titov LP; Tasbiti AH; Yari S; Graviss EA
    J Clin Microbiol; 2009 Sep; 47(9):2744-50. PubMed ID: 19721079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abdella K; Kebede W; Abdissa K; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):185-91. PubMed ID: 27242230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features?
    Escalante P; McKean-Cowdin R; Ramaswamy SV; Williams-Bouyer N; Teeter LD; Jones BE; Graviss EA
    Int J Tuberc Lung Dis; 2013 May; 17(5):644-51. PubMed ID: 23453008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing.
    Soundararajan L; Kambli P; Priyadarshini S; Let B; Murugan S; Iravatham C; Tornheim JA; Rodrigues C; Gupta R; Ramprasad VL
    Tuberculosis (Edinb); 2020 Mar; 121():101915. PubMed ID: 32279871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
    Suthum K; Samosornsuk W; Samosornsuk S
    J Infect Dev Ctries; 2020 Mar; 14(3):268-276. PubMed ID: 32235087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis drug resistance isolates from pulmonary tuberculosis patients, Kassala State, Sudan.
    Khalid FA; Hamid ZA; Mukhtar MM
    Int J Mycobacteriol; 2015 Mar; 4(1):44-7. PubMed ID: 26655197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis isolates in Sichuan, China and the association between Beijing-lineage and dual-mutation in gidB.
    Sun H; Zhang C; Xiang L; Pi R; Guo Z; Zheng C; Li S; Zhao Y; Tang K; Luo M; Rastogi N; Li Y; Sun Q
    Tuberculosis (Edinb); 2016 Jan; 96():102-6. PubMed ID: 26786661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
    Ogari CO; Nyamache AK; Nonoh J; Amukoye E
    BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey.
    Ozturk CE; Sanic A; Kaya D; Ceyhan I
    Jpn J Infect Dis; 2005 Oct; 58(5):309-12. PubMed ID: 16249627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.